Download PDF
Horm Metab Res 2004; 36(8): 571-577
DOI: 10.1055/s-2004-825763
Original Clinical
© Georg Thieme Verlag Stuttgart · New York

Infusion of β-Endorphin Improves Insulin Resistance in Fructose-fed Rats

C.-F.  Su1 , Y.-Y.  Chang2 , H.-H.  Pai1 , I.-M.  Liu3 , C.-Y.  Lo4 , J.-T.  Cheng4
  • 1Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung City
  • 2School of Public Health, Kaohsiung Medical University, Kaohsiung City
  • 3Department of Pharmacy, Tajen Institute of Technology, Yen-Pou, Ping Tung Shien
  • 4Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan City, Taiwan, R.O.C.
Further Information

Publication History

Received 25 November 2003

Accepted after Revision 10 February 2004

Publication Date:
24 August 2004 (online)

Also available at
    Permissions and Reprints

Abstract

In an attempt to probe the effect of β-endorphin on insulin resistance, we used Wistar rats that were fed fructose-rich chow to induce insulin resistance. Insulin action on glucose disposal rate (GDR) was measured using the hyperinsulinemic euglycemic clamp technique, in which glucose (variable), insulin (40 mU/kg/min), and β-endorphin (6 ng/kg/min) or vehicle were initiated simultaneously and continued for 120 min. A marked reduction in insulin-stimulated GDR was observed in fructose-fed rats compared to normal control rats. Infusion of β-endorphin reversed the value of GDR, which was inhibited by naloxone and naloxonazine each at doses sufficient to block opioid µ-receptors. Opioidµ-receptors may therefore be activated by β-endorphin to improve insulin resistance. Next, soleus muscle was isolated to investigate the effect of β-endorphin on insulin signals. Insulin resistance in rats induced by excess fructose was associated with the impaired insulin receptor (IR), tyrosine autophosphorylation, and insulin receptor substrate (IRS)-1 protein content in addition to the significant decrease in IRS-1 tyrosine phosphorylation in soleus muscle. This impaired glucose transportation was also due to signaling defects that included an attenuated p85 regulatory subunit of phosphatidylinositol 3-kinase (PI3-kinase) and Akt serine phosphorylation. However, IR protein levels were not markedly changed in rats with insulin resistance. β-endorphin infusion reversed the fructose-induced decrement in the insulin-signaling cascade with increased GDR. Apart from IR protein levels, infusion of β-endorphin reversed the decrease in protein expression for the IRS-1, p85 regulatory subunit of PI3-kinase, and Akt serine phosphorylation in soleus muscle in fructose-fed rats. The decrease in insulin-stimulated protein expression of glucose transporter subtype 4 (GLUT 4) in fructose-fed rats returned to near-normal levels after β-endorphin infusion. Infusion of β-endorphin may improve insulin resistance by modulating the insulin-signaling pathway to reverse insulin responsiveness.

Key words

Akt · β-Endorphin · Glucose transporter subtype 4 · Insulin receptor · Insulin receptor substrate-1 · Phosphatidylinositol 3-kinase

References

  • 1 Chevlen E. Opioids: a review.  Curr Pain Headache Rep. 2003;  7 15-23
    PubMedGoogle Scholar
  • 2 Yaksh T L. Pharmacology and mechanisms of opioid analgesic activity.  Acta anaesthesiol Scand. 1997;  41 94-111
    PubMedGoogle Scholar
  • 3 Smith E M. Opioid peptides in immune cells.  Adv Exp Med Biol. 2003;  521 51-68
    PubMedGoogle Scholar
  • 4 Curry D L, Li C H. Stimulation of insulin secretion by beta-endorphin (1-27 and 1-31).  Life Sci. 1987;  40 2053-2058
    CrossrefPubMedGoogle Scholar
  • 5 Locatelli A, Spotti D, Caviezel F. The regulation of insulin and glucagon secretion by opiates: a study with naloxone in healthy humans.  Acta Diabetol. 1985;  22 25-31
    PubMedGoogle Scholar
  • 6 Khawaja X Z, Green I C, Thorpe J R, Titheradge M A. The occurrence and receptor specificity of endogenous opioid peptides with pancreas and liver of the rat. Comparison with brain.  Biochem J. 1990;  267 233-240
    PubMedGoogle Scholar
  • 7 Cheng J T, Liu I M, Tzeng T F, Tsai C C, Lai T Y. Plasma glucose lowering effect of β-endorphin in streptozotocin-induced diabetic rats.  Horm Meta Res. 2002;  34 570-576
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Cheng J T, Liu I M, Hsu C F. Rapid induction of insulin resistance in opioid mu-receptor knock-out mice.  Neurosci lett. 2003;  339 139-142
    CrossrefPubMedGoogle Scholar
  • 9 Kruszynska Y T, Olefsky J M. Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus.  J Invest Med. 1996;  44 413-428
    PubMedGoogle Scholar
  • 10 DeFronzo R A. Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview.  Diabetologia. 1992;  35 389-397
    CrossrefPubMedGoogle Scholar
  • 11 Shulman G I. Cellular mechanisms of insulin resistance.  J Clin Invest. 2000;  106 171-176
    CrossrefPubMedGoogle Scholar
  • 12 Higashiura K, Ura N, Takada T, Li Y, Torii T, Togashi N, Takada M, Takizawa H, Shimamoto K. The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats.  Am J Hypertens. 2000;  13 290-297
    CrossrefPubMedGoogle Scholar
  • 13 Lambert K, Py G, Robert E, Mercier J. Does high-sucrose diet alter skeletal muscle and liver mitochondrial respiration?.  Horm Metab Res. 2003;  35 546-550
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Steele R. Influence of glucose loading and injected insulin on hepatic glucose output.  Ann N Y Acad Sci. 1959;  82 420-430
    PubMedGoogle Scholar
  • 15 Bessesen D H. The role of carbohydrates in insulin resistance.  J Nutr. 2001;  131 S2782-S 2786
    PubMedGoogle Scholar
  • 16 James D E, Jenkins A B, Kraegen E W. Heterogeneity of insulin action in individual muscles in vivo: euglycemic clamp studies in rats.  Am J Physiol. 1985;  248 E567-E574
    PubMedGoogle Scholar
  • 17 Kurokawa K, Oka Y. Insulin resistance and glucose transporter.  Nippon Rinsho. 2000;  58 310-314
    PubMedGoogle Scholar
  • 18 King P A, Horton E D, Hirshman M F, Horton E S. Insulin resistance in obese Zucker rat (fa/fa) skeletal muscle is associated with a failure of glucose transporter translocation.  J Clin Invest. 1992;  90 1568-1575
    CrossrefPubMedGoogle Scholar
  • 19 Anai M, Funaki M, Ogihara T, Kanda A, Onishi Y, Sakoda H, Inukai K, Nawano M, Fukushima Y, Yazaki Y, Kikuchi M, Oka Y, Asano T. Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats.  Diabetes. 1999;  48 158-169
    PubMedGoogle Scholar
  • 20 Jiang Z Y, Lin Y W, Clemont A, Feener E P, Hein K D, Igarashi M, Yamauchi T, White M F, King G L. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats.  J Clin Invest. 1999;  104 447-457
    CrossrefPubMedGoogle Scholar
  • 21 White M F. The insulin signalling system and the IRS proteins.  Diabetologia. 1997;  40 S2-S17
    CrossrefPubMedGoogle Scholar
  • 22 Kitamura T, Ogawa W, Sakaue H, Hino Y, Kuroda S, Takata M, Matsumoto M, Maeda T, Konishi H, Kikkawa U, Kasuga M. Requirement for activation of the serine-threonine kinase Akt (protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport.  Mol Cell Biol. 1998;  18 3708-3717
    PubMedGoogle Scholar
  • 23 Klippel A, Kavanaugh W M, Pot D, Williams L T. A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain.  Mol Cell Biol. 1997;  17 338-344
    PubMedGoogle Scholar
  • 24 Lima M H, Ueno M, Thirone A C, Rocha E M, Carvalho C R, Saad M J. Regulation of IRS-1/SHP2 interaction and AKT phosphorylation in animal models of insulin resistance.  Endocrine. 2002;  18 1-12
    CrossrefPubMedGoogle Scholar
  • 25 Carvalho E, Rondinone C, Smith U. Insulin resistance in fat cells from obese Zucker rats - evidence for an impaired activation and translocation of protein kinase B and glucose transporter 4.  Mol Cell Biol. 2000;  206 7-16
    PubMedGoogle Scholar
  • 26 Cusi K, Maezono K, Osman A, Pendergrass M, Patti M E, Pratipanawatr T, DeFronzo R A, Kahn C R, Mandarino L J. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle.  J Clin Invest. 2000;  105 311-320
    CrossrefPubMedGoogle Scholar
  • 27 Goldstein A. Binding selectivity profiles for ligands of multiple receptor types: focus on opioid receptors.  Trends Pharmacol Sci. 1987;  8 456-459
    CrossrefPubMedGoogle Scholar
  • 28 Ishizuka T, Cooper D R, Hernandez H, Buckley D, Standaert M, Farese R V. Effects of insulin on diacylglycerol-protein kinase C signaling in rat diaphragm and soleus muscles and relationship to glucose transport.  Diabetes. 1990;  39 181-190
    CrossrefPubMedGoogle Scholar
  • 29 Van Epps-Fung M, Gupta K, Hardy R W, Wells A. A role for phospholipase C activity in GLUT4-Mediated glucose transport.  Endocrinology. 1997;  138 5170-5175
    CrossrefPubMedGoogle Scholar
  • 30 Narita M, Ohnishi O, Nemoto M, Aoki T, Suzuki T. The involvement of phosphoinositide 3-kinase (PI3-Kinase) and phospholipase C gamma (PLC gamma) pathway in the morphine-induced supraspinal antinociception in the mouse.  Nihon Shinkei Seishin Yakurigaku Zasshi. 2001;  21 7-14
    PubMedGoogle Scholar
  • 31 Freye E, Latasch L. Development of opioid tolerance - molecular mechanisms and clinical consequences.  Anasthesiol Intensivmed Notfallmed Schmerzther. 2003;  38 14-26
    Article in Thieme ConnectPubMedGoogle Scholar
  • 32 Liu I M, Liou S S, Chen W C, Chen P F, Cheng J T. Signals in the activation of opioid µ-receptors by loperamide to enhance glucose uptake into cultured C2C12 cells.  Horm Metab Res. 2004;  36 210-214
    Article in Thieme ConnectPubMedGoogle Scholar
  • 33 Bandyopadhyay G, Standaert ML, Kikkawa U, Ono Y, Moscat J, Farese RV. Effects of transiently expressed atypical (zeta, lambda), conventional (alpha, beta) and novel (delta, epsilon) protein kinase C isoforms on insulin-stimulated translocation of epitope-tagged GLUT4 glucose transporters in rat adipocytes: specific interchangeable effects of protein kinases C-zeta and C-lambda.  Biochem J. 1999;  337 461-470
    CrossrefPubMedGoogle Scholar
  • 34 Vollenweider P, Menard B, Nicod P. Insulin resistance, defective insulin receptor substrate 2-associated phosphatidylinositol-3′ kinase activation, and impaired atypical protein kinase C (zeta/lambda) activation in myotubes from obese patients with impaired glucose tolerance.  Diabetes. 2002;  51 1052-1059
    PubMedGoogle Scholar
  • 35 Ravichandran L V, Esposito D L, Chen J, Quon M J. Protein kinase C-zeta phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin.  J Biol Chem. 2001;  276 3543-3549
    CrossrefPubMedGoogle Scholar
  • 36 Liu I M, Niu C S, Chi T C, Kuo D H, Cheng J T. Investigations of the mechanism of the reduction in plasma glucose by cold-stress in streptozotocin-induced diabetic rats.  Neurosci. 1999;  92 1137-1142
    CrossrefPubMedGoogle Scholar

Prof. J.-T. Cheng

Department of Pharmacology, College of Medicine

National Cheng Kung University · Taiwan City · Taiwan 70101 · R.O.C.

Phone: +886 (6) 237-2706

Fax: +886 (6) 238-6548 ·

Email: jtcheng@mail.ncku.edu.tw